Adicet Bio, Inc.
Hedge Funds Holdings
Last updated:
Adicet Bio, Inc.‘s stocks are currently a part of 60 hedge funds’ portfolios, which represents 43.73% of the total amount of its stocks outstanding. This makes up a total of 17.96M shares of Adicet Bio, Inc.. Compared to the previous quarter, the number fell by -57.27% or -24.07M shares fewer. As for the holding position changes, 21.67% (13) of current hedge fund investors increased the number of shares held, 28.33% (17) of current holders sold a part of the shares held, and 16.67% (10) closed the holdings completely. 15 hedge funds are new holders of Adicet Bio, Inc. stock in Q1 2023, it is 25% of total holders.
Hedge funds holding Adicet Bio (Q1 2018 – Q1 2023)
| Q1 2018 | 1 |
|---|---|
| Q2 2018 | 1 |
| Q3 2018 | 1 |
| Q4 2018 | 1 |
| Q1 2019 | 0 |
| Q2 2019 | 0 |
| Q4 2019 | 0 |
| Q1 2020 | 0 |
| Q2 2020 | 0 |
| Q3 2020 | 29 |
| Q4 2020 | 41 |
| Q1 2021 | 52 |
| Q2 2021 | 64 |
| Q3 2021 | 54 |
| Q4 2021 | 78 |
| Q1 2022 | 84 |
| Q2 2022 | 98 |
| Q3 2022 | 98 |
| Q4 2022 | 100 |
| Q1 2023 | 60 |
Hedge funds changes in Adicet Bio positions (Q1 2018 – Q1 2023)
| Q1 2018 | 1 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q2 2018 | 0 | 0 | 0 | 0 | 1 |
| Q3 2018 | 0 | 0 | 0 | 0 | 1 |
| Q4 2018 | 0 | 0 | 0 | 0 | 1 |
| Q1 2019 | 0 | 0 | 0 | 1 | -1 |
| Q2 2019 | 0 | 0 | 0 | 0 | 0 |
| Q4 2019 | 0 | 0 | 0 | 0 | 0 |
| Q1 2020 | 0 | 0 | 0 | 0 | 0 |
| Q2 2020 | 0 | 0 | 0 | 0 | 0 |
| Q3 2020 | 29 | 0 | 0 | 0 | 0 |
| Q4 2020 | 14 | 11 | 9 | 2 | 5 |
| Q1 2021 | 17 | 20 | 8 | 6 | 1 |
| Q2 2021 | 20 | 18 | 15 | 8 | 3 |
| Q3 2021 | 5 | 22 | 13 | 14 | 0 |
| Q4 2021 | 31 | 31 | 8 | 7 | 1 |
| Q1 2022 | 16 | 32 | 22 | 10 | 4 |
| Q2 2022 | 32 | 34 | 14 | 15 | 3 |
| Q3 2022 | 20 | 42 | 20 | 20 | -4 |
| Q4 2022 | 26 | 30 | 30 | 22 | -8 |
| Q1 2023 | 15 | 13 | 17 | 10 | 5 |
Hedge funds changes in Adicet Bio stock options (Q1 2018 – Q1 2023)
| Q1 2018 | 6,000 | 10,000 |
|---|---|---|
| Q2 2018 | 51,000 | 11,000 |
| Q3 2018 | 4,000 | 1,000 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 25,000 |
| Q2 2019 | 0 | 0 |
| Q4 2019 | 5,000 | 3,000 |
| Q1 2020 | 0 | 34,000 |
| Q2 2020 | 12,000 | 3,000 |
| Q3 2020 | 47,000 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 0 | 2,000 |
| Q3 2021 | 0 | 1,000 |
| Q4 2021 | 4,250,000 | 2,885,000 |
| Q1 2022 | 1,763,000 | 2,022,000 |
| Q2 2022 | 2,187,000 | 1,115,000 |
| Q3 2022 | 2,287,000 | 4,167,000 |
| Q4 2022 | 843,148 | 752,234 |
| Q1 2023 | 597,000 | 28,000 |